| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 3.837 | 8.379 | 9.634 | 12.651 | 14.194 |
| Total Income - EUR | - | - | - | - | - | 3.837 | 8.379 | 9.634 | 12.651 | 14.194 |
| Total Expenses - EUR | - | - | - | - | - | 25 | 90 | 76 | 116 | 81 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 3.811 | 8.289 | 9.558 | 12.535 | 14.113 |
| Net Profit/Loss - EUR | - | - | - | - | - | 3.700 | 8.038 | 9.269 | 10.529 | 11.855 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nephrolen S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 3.884 | 11.750 | 10.040 | 20.455 | 32.251 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 10.668 | 8.515 | 20.206 | 19.547 |
| Cash | - | - | - | - | - | 3.884 | 1.082 | 1.526 | 248 | 12.704 |
| Shareholders Funds | - | - | - | - | - | 3.741 | 11.696 | 9.318 | 19.819 | 31.563 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 143 | 54 | 722 | 636 | 688 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nephrolen S.r.l.